Carglumic Acid is a urea cycle inhibitor used to treat hyperammonemia in patients with N-acetylglutamate synthase deficiency. As an orphan drug, it functions by enhancing the activity of N-acetylglutamate… Read more

















Carglumic Acid is a urea cycle inhibitor used to treat hyperammonemia in patients with N-acetylglutamate synthase deficiency. As an orphan drug, it functions by enhancing the activity of N-acetylglutamate synthase to improve ammonia metabolism. This category provides a comprehensive selection of Carglumic Acid reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. These high-quality materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing. Researchers and analysts rely on these precise standards to ensure the accuracy and reliability of their analytical methods throughout the drug development and manufacturing lifecycle.